AU2002342949A1 - Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other - Google Patents
Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the otherInfo
- Publication number
- AU2002342949A1 AU2002342949A1 AU2002342949A AU2002342949A AU2002342949A1 AU 2002342949 A1 AU2002342949 A1 AU 2002342949A1 AU 2002342949 A AU2002342949 A AU 2002342949A AU 2002342949 A AU2002342949 A AU 2002342949A AU 2002342949 A1 AU2002342949 A1 AU 2002342949A1
- Authority
- AU
- Australia
- Prior art keywords
- valences
- vaccine composition
- enhanced adjuvant
- adjuvant
- enhanced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR01/10573 | 2001-08-08 | ||
| FR0110573A FR2828406B1 (en) | 2001-08-08 | 2001-08-08 | BIVALENT HAVI VACCINE COMPOSITION |
| PCT/FR2002/002770 WO2003013600A1 (en) | 2001-08-08 | 2002-07-31 | Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002342949A1 true AU2002342949A1 (en) | 2003-06-19 |
| AU2002342949B2 AU2002342949B2 (en) | 2007-07-05 |
Family
ID=8866367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002342949A Expired AU2002342949B2 (en) | 2001-08-08 | 2002-07-31 | Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7404960B2 (en) |
| EP (1) | EP1416958B2 (en) |
| JP (1) | JP4221291B2 (en) |
| KR (1) | KR100881703B1 (en) |
| CN (1) | CN1282486C (en) |
| AT (1) | ATE357929T1 (en) |
| AU (1) | AU2002342949B2 (en) |
| BR (1) | BRPI0211151B8 (en) |
| CA (1) | CA2455406C (en) |
| CY (1) | CY1107619T1 (en) |
| DE (1) | DE60219177T3 (en) |
| DK (1) | DK1416958T4 (en) |
| ES (1) | ES2284940T5 (en) |
| FR (1) | FR2828406B1 (en) |
| HU (1) | HU228216B1 (en) |
| IL (2) | IL159519A0 (en) |
| MX (1) | MXPA04001125A (en) |
| NZ (1) | NZ530727A (en) |
| PL (1) | PL215134B1 (en) |
| PT (1) | PT1416958E (en) |
| WO (1) | WO2003013600A1 (en) |
| ZA (1) | ZA200400022B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2738682A1 (en) * | 2004-04-15 | 2005-10-15 | Eng-Hong Lee | Soft gel delivery system for treating poultry |
| AU2007293672B2 (en) * | 2006-09-07 | 2013-06-27 | Glaxosmithkline Biologicals S.A. | Vaccine |
| KR101101901B1 (en) * | 2009-01-30 | 2012-01-02 | 주식회사 리노 | Kitchen shelves |
| BRPI1009828A2 (en) | 2009-03-24 | 2019-03-12 | Novartis Ag | meningococcal h factor binding protein adjuvant |
| CN102526724B (en) * | 2011-01-14 | 2015-07-22 | 四川大学 | Aluminum hydroxide gel-polysaccharide composite immunologic adjuvant and preparation method and application thereof |
| FR2985663B1 (en) * | 2012-01-17 | 2015-03-27 | Sanofi Pasteur | METHOD FOR FORMULATING A VACCINE CONTAINING AT LEAST TWO ANTIGENS THAT CAN ADEQUATE ON ALUMINUM OXY HYDROXIDE |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2734484B1 (en) * | 1995-05-24 | 1997-06-27 | Pasteur Merieux Serums Vacc | LIQUID VACCINE COMPOSITION AND MANUFACTURING METHOD |
| GB9806456D0 (en) * | 1998-03-25 | 1998-05-27 | Smithkline Beecham Biolog | Vaccine composition |
| AU5739999A (en) * | 1998-08-28 | 2000-03-21 | Smithkline Beecham Biologicals (Sa) | Salmonella typhi vaccine compositions |
| US6585973B1 (en) * | 1998-10-29 | 2003-07-01 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method for preparing solid phase conjugated vaccine |
| GB9909077D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
-
2001
- 2001-08-08 FR FR0110573A patent/FR2828406B1/en not_active Expired - Lifetime
-
2002
- 2002-07-31 JP JP2003518604A patent/JP4221291B2/en not_active Expired - Lifetime
- 2002-07-31 IL IL15951902A patent/IL159519A0/en unknown
- 2002-07-31 MX MXPA04001125A patent/MXPA04001125A/en active IP Right Grant
- 2002-07-31 KR KR1020047001923A patent/KR100881703B1/en not_active Expired - Lifetime
- 2002-07-31 CN CNB028156455A patent/CN1282486C/en not_active Expired - Lifetime
- 2002-07-31 DE DE60219177T patent/DE60219177T3/en not_active Expired - Lifetime
- 2002-07-31 EP EP02779603A patent/EP1416958B2/en not_active Expired - Lifetime
- 2002-07-31 NZ NZ530727A patent/NZ530727A/en not_active IP Right Cessation
- 2002-07-31 ES ES02779603T patent/ES2284940T5/en not_active Expired - Lifetime
- 2002-07-31 BR BR0211151-9 patent/BRPI0211151B8/en not_active IP Right Cessation
- 2002-07-31 AU AU2002342949A patent/AU2002342949B2/en not_active Expired
- 2002-07-31 WO PCT/FR2002/002770 patent/WO2003013600A1/en not_active Ceased
- 2002-07-31 DK DK02779603.6T patent/DK1416958T4/en active
- 2002-07-31 AT AT02779603T patent/ATE357929T1/en active
- 2002-07-31 CA CA2455406A patent/CA2455406C/en not_active Expired - Lifetime
- 2002-07-31 PL PL367904A patent/PL215134B1/en unknown
- 2002-07-31 US US10/485,748 patent/US7404960B2/en not_active Expired - Lifetime
- 2002-07-31 PT PT02779603T patent/PT1416958E/en unknown
- 2002-07-31 HU HU0401182A patent/HU228216B1/en unknown
-
2003
- 2003-12-22 IL IL159519A patent/IL159519A/en unknown
-
2004
- 2004-01-05 ZA ZA200400022A patent/ZA200400022B/en unknown
-
2007
- 2007-04-16 CY CY20071100521T patent/CY1107619T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03008961A (en) | Vaccine composition. | |
| EG24742A (en) | Vaccine composition. | |
| AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
| AU2002236159A1 (en) | Immunogenic complex | |
| IL162266A0 (en) | Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the useof the same | |
| AU2002319320A1 (en) | Substituted isoxazoles and the use thereof as antibiotics | |
| MXPA03004932A (en) | Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors. | |
| MXPA03007915A (en) | Vaccine. | |
| AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
| AU6600300A (en) | Pneumococcal vaccines | |
| AU2002307971A1 (en) | Vaccine against the nile fever virus | |
| MXPA03006989A (en) | Modified leptin with reduced immunogenicity. | |
| MXPA03007838A (en) | Modified interferon alpha with reduced immunogenicity. | |
| HUP0401157A3 (en) | Methyl-thieno-benzodiazepine lyophilized formulation, its preparation and use | |
| AU2002212049A1 (en) | Novel silicone material, its preparation method and the use thereof | |
| AU2002342949A1 (en) | Vaccine composition comprising at least two valences, one with enhanced adjuvant and not the other | |
| HUP0401182A3 (en) | Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other | |
| AU2001261317A1 (en) | Immunostimulant compositions and associated methods | |
| MXPA03007625A (en) | Modified thrombopoietin with reduced immunogenicity. | |
| AU2002320079A1 (en) | Vaccines, immunotherapeutics and methods of using the same | |
| AU2002304165A1 (en) | Polynucleotide vaccine | |
| IL152808A0 (en) | Vaccines, immunotherapeutics and methods for using the same | |
| GB2372247B (en) | Kiln furniture or the like | |
| AU2002303093A1 (en) | Mycobacterial vaccines | |
| ZA200208250B (en) | Novel mycoplasma strains and the use thereof. |